Literature DB >> 16583191

[Morphology of drug induced liver damage].

H-U Kasper1, U Drebber, I Hirsch, H P Dienes.   

Abstract

Hepatotoxicity is a significant complication of therapeutic drug use. As ist can imitate nearly all hepatopathies, the diagnosis of drug-induced liver disease is difficult. Most often, it is a diagnosis of exclusion. The following morphological changes are known, dependent on the target cell type: acute and chronic hepatitis, granuloma formation, and fatty liver disease, cholestatic type acute and chronic liver damage with or without inflammation,or mixed forms of liver injury. Portal or perisinusoidal fibrosis can occur following each type of liver damage. Vascular changes or neoplasms are rare. Drug induced liver injuries are more likely induced by type B damage, which is not expected and cannot be reproduced in animal testing. Type A damage, which is known from toxicity assays, is less likely. A specific therapeutic regime is not available. Therefore, early recognition and cessation of the use of the drug is necessary.

Entities:  

Mesh:

Year:  2006        PMID: 16583191     DOI: 10.1007/s00292-006-0826-1

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  15 in total

1.  Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States.

Authors:  George Ostapowicz; Robert J Fontana; Frank V Schiødt; Anne Larson; Timothy J Davern; Steven H B Han; Timothy M McCashland; A Obaid Shakil; J Eileen Hay; Linda Hynan; Jeffrey S Crippin; Andres T Blei; Grace Samuel; Joan Reisch; William M Lee
Journal:  Ann Intern Med       Date:  2002-12-17       Impact factor: 25.391

2.  Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge.

Authors:  C Benichou; G Danan; A Flahault
Journal:  J Clin Epidemiol       Date:  1993-11       Impact factor: 6.437

3.  [Score of suspected drug-induced acute liver disorders. Presentation of an evaluation sheet].

Authors:  G Danan; C Benichou; A Flahault
Journal:  Gastroenterol Clin Biol       Date:  1993

4.  Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions.

Authors:  G P Aithal; M D Rawlins; C P Day
Journal:  J Hepatol       Date:  2000-12       Impact factor: 25.083

5.  Comparison of two clinical scales for causality assessment in hepatotoxicity.

Authors:  M I Lucena; R Camargo; R J Andrade; C J Perez-Sanchez; F Sanchez De La Cuesta
Journal:  Hepatology       Date:  2001-01       Impact factor: 17.425

Review 6.  Drug-induced hepatotoxicity: 2005.

Authors:  Willis C Maddrey
Journal:  J Clin Gastroenterol       Date:  2005-04       Impact factor: 3.062

Review 7.  Fulminant hepatic failure: summary of a workshop.

Authors:  J H Hoofnagle; R L Carithers; C Shapiro; N Ascher
Journal:  Hepatology       Date:  1995-01       Impact factor: 17.425

Review 8.  [Toxic liver injuries].

Authors:  St Krähenbühl
Journal:  Ther Umsch       Date:  2004-08

9.  Etiology and outcome for 295 patients with acute liver failure in the United States.

Authors:  F V Schiodt; E Atillasoy; A O Shakil; E R Schiff; C Caldwell; K V Kowdley; R Stribling; J S Crippin; S Flamm; K A Somberg; H Rosen; T M McCashland; J E Hay; W M Lee
Journal:  Liver Transpl Surg       Date:  1999-01

Review 10.  Drug-induced hepatic disorders. Incidence, management and avoidance.

Authors:  M Døssing; J Sonne
Journal:  Drug Saf       Date:  1993-12       Impact factor: 5.606

View more
  1 in total

Review 1.  [Histopathology in liver transplantation].

Authors:  U Drebber; H P Dienes
Journal:  Pathologe       Date:  2008-02       Impact factor: 1.011

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.